Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Eur J Surg Oncol. 2021 Apr 17;47(10):2667–2674. doi: 10.1016/j.ejso.2021.04.013

Table 4.

Postoperative complications.

Variables All patient
N = 201
<70 years-old
N = 136
70+ years-old
N = 65
p-value

Overall postoperative complications, n (%) 105 (52) 67 (49) 38 (58) 0.222
Complications by Grade
Grade II, n (%) 87 (43) 51 (38) 36 (55) 0.017
Grade III, n (%) 50 (25) 35 (26) 15 (23) 0.683
Grade IV, n (%) 10 (5) 5 (4) 5 (8) 0.298
Grade V, n (%) 1 (0.5) 0 (0) 1 (1.5) 0.323
Complications by Organ System
Neurologic, n (%)
delirium 19 (9) 7 (5) 12 (18) 0.004
Cardiovascular, n (%)
Atrial Fibrillation 40 (20) 25 (18) 15 (23) 0.436
Pulmonary, n (%)
Pneumonia 18 (9) 13 (10) 5 (8) 0.795
Respiratory Failure 8 (4) 5 (4) 3 (5) 0.715
Gastrointestinal, n (%)
Esophageal Leak 10 (5) 6 (4) 4 (6) 0.595
Chyle Leak, n (%) 14 (7) 9 (7) 7 (8) 0.773
Genitourinary, n (%)
Urinary Retention 6 (3) 0 6 (9) 0.001
Acute kidney injury/Renal Failure 21 (10) 15 (3) 6 (9) 0.696
Sepsis, n (%) 2 (1) 0 2 (3) 0.103
Transfusion, n (%) 17 (8) 8 (6) 9 (14) 0.100
Return to operating room 31 (15) 21 (15) 10 (15) 1.000
Hospital LOS, days, median (range) 9 (6–56) 9 (6–47) 10 (6–56) 0.155
Disposition 0.491
Home, n (%) 7 (3.5) 4 (3) 3 (5)
Home with services, n (%) 168 (84) 117 (86) 51 (80)
Rehabilitation facility, n (%) 25 (12.5) 15 (11) 10 (16)
Overall Survival (from time of surgery to death or last known follow up)a
30-day mortality (n = 201) 1 (0.5) 0 (0) 1 (1.5) 0.1
90-day mortality (n = 199) 4 (2.0) 2 (1.5) 2 (3.1) 0.4
1-year mortality (n = 187) 22 (12.0) 12 (9.6) 10 (17.3) 0.2

LOS = Length of stay.

a

Not all patients had 90-days or 1-year of follow up data available at time of the study completion. Rates are reported out of those with sufficient follow enough time (n = 201 for 30-day, n = 199 for 90-day, n = 187 for 1-year follow up).